Document Detail

Organic chemicals from bioprocesses in china.
MedLine Citation:
PMID:  20549466     Owner:  NLM     Status:  In-Data-Review    
Over the last 20 years, China has successfully established a modern biotechnology industry from almost nothing. Presently, China is a major producer of a vast array of products involving bioprocesses, for some China is even the world's top producer. The ever-increasing list of products includes organic acids, amino acids, antibiotics, solvents, chiral chemicals, biopesticides, and biopolymers. Herein, the research and development of bioprocesses in China will be reviewed briefly. We will concentrate on three categories of products: small molecules produced via fermentation, biopolymers produced via fermentation and small chemicals produced by enzyme-catalyzed reactions. In comparison with the traditional chemical process, in which, nonrenewable mineral resources are generally used, products in the first and second categories noted above can use renewable bioresources as raw materials. The bioprocesses are generally energy saving and environmentally benign. For products developed via the third category, although the raw materials still need to be obtained from mineral resources, the biocatalysts are more effective with higher selectivity and productivity, and the bioprocesses occur under ambient temperature and pressure, therefore, these are "green processes." Most of the products such as citric acid, xanthan and acrylamide etc., discussed in this paper have been in large-scale commercial production in China. Also introduced herein are three scientists, Prof. Shen Yinchu, Prof. Ouyang Pingkai and Prof. Chen Guoqiang, and six enterprises, Anhui Fengyuan Biochemical Co. Ltd., Shandong Hiland Biotechnology Co. Ltd., Shandong Fufeng Fermentation Co. Ltd., Shandong Bausch & Lomb-Freda Pharmaceutical Co. Ltd., Zhejiang Hangzhou Xinfu Pharmaceutical Co. Ltd., and Changzhou Changmao Biochemical Engineering Co. Ltd.; they have all contributed a great deal to research and development in the commercialization of bioprocesses.
Jin Huang; Lei Huang; Jianping Lin; Zhinan Xu; Peilin Cen
Related Documents :
24837926 - Phenolic compounds, organic acids and antioxidant activity of grape juices produced fro...
9580346 - Mechanisms underlying the transport and intracellular metabolism of acetic acid in the ...
17223216 - Surface hydrolysis of polyacrylonitrile with nitrile hydrolysing enzymes from micrococc...
335966 - Rapid microdilution-colorimetric assay for yeast susceptibility to fluorocytosine.
11842876 - Amino acid levels and ratios in serum and cerebrospinal fluid of patients with optic ne...
22654766 - Fish, marine n-3 fatty acids, and atrial fibrillation - experimental data and clinical ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in biochemical engineering/biotechnology     Volume:  122     ISSN:  1616-8542     ISO Abbreviation:  Adv. Biochem. Eng. Biotechnol.     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8307733     Medline TA:  Adv Biochem Eng Biotechnol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  43-71     Citation Subset:  IM    
Department of Chemical Engineering and Biological Engineering, Zhejiang University (Yuquan Campus), Hangzhou, 310027, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preventing a pitfall: no-knife staplers that require caution during handling.
Next Document:  Induced pluripotent stem cells: characteristics and perspectives.